{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T09:46:33Z","timestamp":1775295993908,"version":"3.50.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/j.heliyon.2019.e01462","type":"journal-article","created":{"date-parts":[[2019,4,11]],"date-time":"2019-04-11T09:38:49Z","timestamp":1554975529000},"page":"e01462","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["In silico study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of Candida albicans fructose-1,6-bisphosphate aldolase II"],"prefix":"10.1016","volume":"5","author":[{"given":"Ivan V.","family":"Semenyuta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oleksandr L.","family":"Kobzar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana M.","family":"Hodyna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Volodymyr S.","family":"Brovarets","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Larysa O.","family":"Metelytsia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2019.e01462_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-4939-6515-1_2","article-title":"The changing epidemiology of invasive fungal infections","volume":"1508","author":"Enoch","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib2","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.drudis.2018.01.003","article-title":"Targeting Candida spp. to develop antifungal agents","volume":"23","author":"Salci","year":"2018","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.heliyon.2019.e01462_bib3","first-page":"70","article-title":"Antifungal drug discovery: something old and something","volume":"8","author":"Goldman","year":"2012","journal-title":"New PLoS Pathog."},{"key":"10.1016\/j.heliyon.2019.e01462_bib4","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2165\/11585270-000000000-00000","article-title":"Echinocandin antifungal drugs in fungal infections: a comparison","volume":"71","author":"Chen","year":"2011","journal-title":"Drugs"},{"key":"10.1016\/j.heliyon.2019.e01462_bib5","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1128\/AAC.34.2.183","article-title":"Amphotericin B: current understanding of the mechanisms of action","volume":"34","author":"Brajtburg","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.heliyon.2019.e01462_bib6","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.heliyon.2019.e01462_bib7","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 by antifungal imidazole derivatives, Drug Metab","volume":"30","author":"Zhang","year":"2002","journal-title":"Dispos"},{"key":"10.1016\/j.heliyon.2019.e01462_bib8","first-page":"48","article-title":"Evolution of aldolase, fed","volume":"23","author":"Rutter","year":"1964","journal-title":"SAVE Proc."},{"key":"10.1016\/j.heliyon.2019.e01462_bib9","first-page":"71","article-title":"Effects of depleting the essential central metabolic enzyme fructose-1,6-bisphosphate aldolase on the growth and viability of Candida albicans: implications for antifungal drug target discovery","volume":"8","author":"Rodaki","year":"2006","journal-title":"Eukaryot. Cell"},{"key":"10.1016\/j.heliyon.2019.e01462_bib10","first-page":"219","article-title":"Glycolytic and non-glycolytic functions of Mycobacterium tuberculosis fructose-1,6-bisphosphate aldolase, an essential enzyme produced by replicating and non-replicating bacilli","volume":"46","author":"de la Paz Santangelo","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib11","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1046\/j.1365-2958.2003.03404.x","article-title":"Regulation of the central glycolytic genes in Bacillus subtilis: binding of the repressor CggR to its single DNA target sequence is modulated by fructose-1,6-bisphosphate","volume":"47","author":"Doan","year":"2003","journal-title":"Mol. Microbiol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib12","doi-asserted-by":"crossref","first-page":"8521","DOI":"10.1002\/chem.200800857","article-title":"Synthesis and biochemical evaluation of selective inhibitors of Class II fructose bisphosphate aldolases: towards new synthetic antibiotics","volume":"14","author":"Fonvielle","year":"2008","journal-title":"Chem. Eur J."},{"key":"10.1016\/j.heliyon.2019.e01462_bib13","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2004.02628.x","article-title":"Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse","volume":"138","author":"Ling","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib14","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1134\/S1070363212040056","article-title":"Reaction of diethyl 1-acylamino-2,2-dichloroethenylphosphonates with amino acids esters","volume":"82","author":"Kondratyuk","year":"2012","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib15","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1134\/S1070363213010088","article-title":"Synthesis and some properties of 4-phosphorylated derivatives of 5-mercapto-1,3-oxazoles","volume":"83","author":"Kondratyuk","year":"2013","journal-title":"Russ. J. Gen. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/ajcp\/45.4_ts.493","article-title":"Antibiotic susceptibility testing by a standardized single disk method","volume":"45","author":"Bauer","year":"1966","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib19","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0022-2836(05)80360-2","article-title":"Basic local alignment search tool","volume":"215","author":"Altschul","year":"1990","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib20","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.heliyon.2019.e01462_bib21","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1186\/1471-2105-10-421","article-title":"BLAST+: architecture and applications","volume":"10","author":"Camacho","year":"2009","journal-title":"BMC Bioinf."},{"key":"10.1016\/j.heliyon.2019.e01462_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/nmeth.1818","article-title":"HHblits: lightning-fast iterative protein sequence searching by HMM-HMM alignment","volume":"9","author":"Remmert","year":"2012","journal-title":"Nat. Methods"},{"key":"10.1016\/j.heliyon.2019.e01462_bib23","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1002\/pro.5560020916","article-title":"Verification of protein structures: patterns of nonbonded atomic interactions","volume":"2","author":"Colovos","year":"1993","journal-title":"Protein Sci."},{"key":"10.1016\/j.heliyon.2019.e01462_bib24","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1107\/S0021889892009944","article-title":"PROCHECK - a program to check the stereochemical quality of protein structures","volume":"26","author":"Laskowski","year":"1993","journal-title":"J. App. Cryst."},{"key":"10.1016\/j.heliyon.2019.e01462_bib25","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.compbiolchem.2016.09.012","article-title":"1,3-Oxazole derivatives as potential anticancer agents: computer modeling and experimental study","volume":"65","author":"Semenyuta","year":"2016","journal-title":"Comput. Biol. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib26","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.molstruc.2017.02.079","article-title":"Synthesis, spectroscopic and molecular docking studies of imidazolium and pyridinium based ionic liquids with HSA as potential antimicrobial agents","volume":"1137","author":"Trush","year":"2017","journal-title":"J. Mol. Struct."},{"key":"10.1016\/j.heliyon.2019.e01462_bib27","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.compbiolchem.2018.04.006","article-title":"Design, synthesis and evaluation of novel sulfonamides as potential anticancer agents","volume":"74","author":"Kachaeva","year":"2018","journal-title":"Comp. Biol. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib28","first-page":"57","article-title":"Python: a programming language for software integration and development","volume":"17","author":"Sanner","year":"1999","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.heliyon.2019.e01462_bib29","series-title":"Discovery Studio","author":"Dassault Syst\u00e8mes BIOVIA","year":"2018"},{"key":"10.1016\/j.heliyon.2019.e01462_bib30","series-title":"ChemAxon MarvinSketch","year":"2018"},{"key":"10.1016\/j.heliyon.2019.e01462_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1758-2946-4-17","article-title":"Avogadro: an advanced semantic chemical editor, visualization, and analysis platform","volume":"4","author":"Hanwell","year":"2012","journal-title":"J. Cheminf."},{"key":"10.1016\/j.heliyon.2019.e01462_bib32","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"Autodock4 and AutoDockTools4: automated docking with selective receptor flexiblity","volume":"16","author":"Morris","year":"2009","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib33","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1021\/acs.jcim.6b00763","article-title":"Structure-based rational design of novel inhibitors against fructose-1,6-bisphosphate aldolase from Candida albicans","volume":"57","author":"Han","year":"2017","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.heliyon.2019.e01462_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1021\/bi401022b","article-title":"A noncompetitive inhibitor for Mycobacterium tuberculosis's class IIa fructose 1,6-bisphosphate aldolase","volume":"53","author":"Capodagli","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2019.e01462_bib38","series-title":"ChemAxon Instant JChem","year":"2018"},{"key":"10.1016\/j.heliyon.2019.e01462_bib40","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jmb.2009.01.003","article-title":"Structural basis for catalysis of a tetrameric class IIa fructose 1,6-bisphosphate aldolase from Mycobacterium tuberculosis","volume":"386","author":"Pegan","year":"2009","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1006\/jmbi.1999.2609","article-title":"The crystal structure of Escherichia coli class II fructose-1,6-bisphosphate aldolase in complex with phosphoglycolohydroxamate reveals details of mechanism and specificity","volume":"287","author":"Hall","year":"1999","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.heliyon.2019.e01462_bib42","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/128_2014_561","article-title":"Prodrugs of phosphonates and phosphates: crossing the membrane barrier","volume":"360","author":"Wiemer","year":"2015","journal-title":"Top. Curr. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib43","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.3762\/bjoc.13.219","article-title":"Phosphonic acid: preparation and applications","volume":"13","author":"Sevrain","year":"2017","journal-title":"Beilstein J. Org. Chem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib44","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12291-013-0408-y","article-title":"Alkaline phosphatase: an overview","volume":"29","author":"Sharma","year":"2014","journal-title":"Indian J. Clin. Biochem."},{"key":"10.1016\/j.heliyon.2019.e01462_bib45","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1021\/bi012166y","article-title":"Alkaline phosphatase revisited: hydrolysis of alkyl phosphates","volume":"41","author":"O'Brien","year":"2002","journal-title":"Biochemistry"},{"key":"10.1016\/j.heliyon.2019.e01462_bib46","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1139\/W08-029","article-title":"Inhibition of Candida albicans extracellular enzyme activity by selected natural substances and their application in Candida infection","volume":"54","author":"Yordanov","year":"2008","journal-title":"Can. J. Microbiol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584401835953X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240584401835953X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T10:31:15Z","timestamp":1762511475000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240584401835953X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S240584401835953X"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01462","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In silico study of 4-phosphorylated derivatives of 1,3-oxazole as inhibitors of Candida albicans fructose-1,6-bisphosphate aldolase II","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2019.e01462","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e01462"}}